언어 선택
무료 등록

H-2Kb | B2M

제품 문의

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
LM-305LM-305Phase 2 ClinicalLaNova Medicines LtdMultiple Myeloma
상세
SAR-446523SAR-446523Phase 2 ClinicalSanofi-Aventis GmbhBone Marrow Neoplasms; Multiple Myeloma
상세
Anti-GPRC5D CAR-T Cells Therapy (Shanghai YaKe Biotechnology)Phase 2 ClinicalShanghai YaKe Biotechnology Co LtdMultiple Myeloma
상세
IBI-3003IBI3003; IBI-3003Phase 2 ClinicalInnovent Biologics(Suzhou) Co LtdMultiple Myeloma
상세
BCMA-GPRC5D CAR-T Cells Therapy(Wuhan Union Hospital)Phase 2 ClinicalGuangzhou Bio-Gene Technology Co Ltd, Wuhan Union HospitalMultiple Myeloma
상세
MBS-314MBS-314Phase 2 ClinicalBeijing Mabworks Biotech Co LtdMultiple Myeloma
상세
CT-071CT071; CT-071Phase 2 ClinicalCARsgen Therapeutics Holdings LtdLeukemia, Plasma Cell; Multiple Myeloma
상세
Anti-GPRC5D CAR-T Cells Therapy（920th Hospital）Phase 2 ClinicalThe 920th Hospital Of Joint Logistics Support Force Of PLAMultiple Myeloma
상세
Ori-CAR-017Ori-CAR-017; OriCAR-017; GPRC5D-CAR-TPhase 2 ClinicalOriCell Therapeutics Co LtdHematologic Diseases; Hemorrhagic Disorders; Immunoproliferative Disorders; Hemostatic Disorders; Paraproteinemias; Neoplasms; Blood Protein Disorders; Multiple Myeloma; Immune System Diseases; Vascular Diseases; Neoplasms, Plasma Cell; Cardiovascular Diseases; Lymphoproliferative Disorders
상세
LBL-034LBL-034Phase 2 ClinicalNeoplasms; Multiple Myeloma
상세
CC-95266CC-95266; BMS986393; BMS-986393Phase 2 ClinicalJuno Therapeutics IncMultiple Myeloma
상세
RD-140RD140Phase 1 ClinicalNanjing Iaso Biotherapeutics Co LtdLeukemia, Plasma Cell; Multiple Myeloma
상세
BCMAxGPRC5D CAR-T therapy (Juno Therapeutics)BMS-986453Phase 1 ClinicalJuno Therapeutics IncMultiple Myeloma
상세
SIM-0500SIM0500; SIM-0500Phase 1 ClinicalSimcere Pharmaceutical Group LtdBone Marrow Neoplasms; Multiple Myeloma
상세
QLS-32015QLS-32015; QLS32015Phase 1 ClinicalQilu Pharmaceutical Co LtdMultiple Myeloma
상세
OriC-321OriC-321; Ori-C-321Phase 1 ClinicalZhejiang University, OriCell Therapeutics Co LtdMultiple Myeloma
상세
CAR-GPRC5DCAR-GPRC5DPhase 1 ClinicalNanjing Iaso Biotherapeutics Co LtdLeukemia, Plasma Cell; Multiple Myeloma
상세
ForimtamigRG-6234Phase 1 ClinicalF. Hoffmann-La Roche LtdMultiple Myeloma
상세
MCARH-109Phase 1 ClinicalMemorial Sloan Kettering Cancer Center, Juno Therapeutics Inc, Eureka Therapeutics IncMultiple Myeloma
상세
RO-7425781RO-7425781Phase 1 ClinicalF. Hoffmann-La Roche LtdMultiple Myeloma
상세
Anti-GPRC5D-CD19-CAR-T cell therapy(The Second People Hospital Of Guangdong Province)The Second People Hospital Of Guangdong Province
상세
Anti-GPRC5D CAR-T Cells Therapy（Institute of Hematology & Blood Diseases Hospital）Institute Of Hematology & Blood Diseases Hospital
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
TalquetamabJNJ-7564; JNJ-64407564ApprovedGenmab A/S, Johnson & Johnson Innovative MedicineTALVEYUnited StatesMultiple MyelomaJanssen Biotech Inc2023-08-09Hematologic Neoplasms; Multiple Myeloma
상세
  • 제품 문의
  • 시판 약물 정보
  • 임상 약물 정보
공유하기:

참여하기법적 규정사이트맵개인정보 정책약관 및 조건
웹사이트 피드백
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

이메일
order.kr@acrobiosystems.com

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호